Notice on Convening the 2024 Annual General Meeting
Filed with SSE · · 8 pages · Chinese
Shaanxi Meibang Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Shaanxi Meibang Pharmaceutical
- Announcement on Cancellation of Partial Accounts for Raised Funds
- Announcement on Serious Abnormal Fluctuations in Stock Trading
- Announcement on Severe Abnormal Fluctuations in Stock Trading and Risk Warning
- Announcement on Resolution of the 4th Extraordinary General Meeting in 2024
- Announcement on Redemption at Maturity of Temporarily Idle Raised Funds Used for Cash Management
Later from Shaanxi Meibang Pharmaceutical
- Report for Q1 2025
- Announcement on Attending 2025 Collective Reception Day for Investors of Listed Companies in Shaanxi Jurisdiction and 2024 Annual Performance Briefing
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Share Reduction Plan for Shareholders
- Announcement on Redemption of Temporarily Idle Raised Funds Used for Cash Management upon Expiration and Continuously Conducting Cash Management
Follow Shaanxi Meibang Pharmaceutical into a list and get an email when it puts out news.
Follow Shaanxi Meibang Pharmaceutical